ATR 1072 in Participants With PRKAG2 Syndrome

计划入组 37 人 · 首次发布于 2026 年 7 月 31 日

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

计划入组 2 人 · 首次发布于 2008 年 11 月 24 日

Prevalence of Lysosomal Hydrolase Alpha-glagtosidase Deficiency in Patients With Antiphospholipid Syndrome.

计划入组 100 人 · 首次发布于 2017 年 12 月 27 日

Leigh syndrome therapeutic(Leigh syndrome)

ORAI-XXXX

Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine (Vero Cell),Inactivated

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Atrium Therapeutics Secures FDA Clearance of IND for ATR-1072, First Disease-Modifying Therapy for PRKAG2 Syndrome

Cardiomyopathy Market Projected to Reach $20+ Billion by 2035 as Novel Therapies Advance Through Clinical Development

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb for Second Lead Compound in Cardiovascular RNA Collaboration